Clinical Trials List
2026-01-02 - 2029-06-30
Phase II/III
Not yet recruiting1
ICD-10C74.00
Malignant neoplasm of cortex of unspecified adrenal gland
ICD-10C74.01
Malignant neoplasm of cortex of right adrenal gland
ICD-10C74.02
Malignant neoplasm of cortex of left adrenal gland
ICD-10C74.10
Malignant neoplasm of medulla of unspecified adrenal gland
ICD-10C74.11
Malignant neoplasm of medulla of right adrenal gland
ICD-10C74.12
Malignant neoplasm of medulla of left adrenal gland
ICD-10C74.90
Malignant neoplasm of unspecified part of unspecified adrenal gland
ICD-10C74.91
Malignant neoplasm of unspecified part of right adrenal gland
ICD-10C74.92
Malignant neoplasm of unspecified part of left adrenal gland
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9194.0
Malignant neoplasm of adrenal gland
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 湯文誠 無
- Ming-Mo Hou 無
- Wen-Chi Chou 無
- Po-Jung Su 無
- Chia-Hsun Hsieh 無
- 陳建銘 無
- Hung-Chih Hsu 無
- Chan-Keng Yang 無
- 黃振洋 無
- Wen-Chi Shen 無
- Yung-Chia Kao 無
- 黃文冠 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
440 participants
